Trial intelligence / Profile preview

Hydroxycitrate for Calcium Phosphate Urinary Stones

NCT06003348Phase 4Recruiting

Sponsor
UT Southwestern Medical Center
Start
Dec 2023
Primary completion
May 2028
Countries
1
01

Overview

A Phase 4 trial of hydroxycitrate in Calcium phosphate kidney stone, sponsored by UT Southwestern Medical Center. Started Dec 2023; status: recruiting.

02

Drugs

hydroxycitrate
03

Conditions

Calcium phosphate kidney stone

Beyond the preview

Go deeper on NCT06003348.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06003348.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call